Prevalence of microalbuminuria in patients with non-diabetic acute ischemic stroke

Muralidhara N, Ravindra Rajanna, Shivakumar Varakanahalli, Vijay Kumar Goyal


Background: Microalbuminuria has been associated with clinical risk factors for stroke like diabetes, hypertension, aging, history of myocardial infarction, obesity, smoking and left ventricular hypertrophy. The present study is aimed to determine the potential use of microalbuminurea, as a marker of stroke risk and its outcome in non-diabetic population.

Methods: The present study was conducted in the department of internal medicine and department of neurology after the institutional ethical clearance and the informed consent from all the subjects. A total of 116 patients admitted with acute ischemic stroke presenting within 24 hours of stroke onset were recruited for the study. The microalbuminurea was assayed by immunoprecipitation. The stroke severity was assessed by NIH Stroke Severity Statistical Software Package. P value less than 0.05 was considered the level of significance.

Results: There was graded co-relation between NIHSSS score and urine albumin creatinine ratio with significant P value of <0.001 in group A, but no such co-relation was seen in group B (P value 0.2). This suggests more the elevated urine ACR more the neurodefecit implying its utility as prognostic marker in acute ischemic stroke.  

Conclusion: Urine albumin excretion had the strongest correlation with the NIHSSS Score of the patient in acute ischemic stroke. Therefore, measurement of microalbuminurea may help to assess those who are at increased risk and to triage those who may need a more aggressive management protocol.



Microalbuminurea, Acute ischemic stroke, NIHSSS score

Full Text:



Goldstein L. Evidence-based medicine and stroke. Neuroepidemiology. 1999;18:120-4.

Hankey GJ. Stroke: how large a public health problem and how can the neurologist help? Arch Neurol. 1999;56:748-54.

Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-26.

Rush University Hypertension Center. Microalbuminuria: what is it why is it important? What should be done about it? J Clin Hypertens. 2001;3(2):99-100.

Parving HH, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy; a longitudinal study of urinary albumin excretion. Acta Endocrinal (Copenti). 1982;100:550-5.

Viberti GC, Hill RD, Jarpet RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet. 1982;1:1430-2.

Keen H, Chlouverakis C. Urine albumin excretion and diabetes. Lancet. 1964;14:1155-7.

Beamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic stroke. Arch Neurol. 1999;56:699-702.

P. C. Mathur, Prashant Punekar, Rajesh Muralidharan. Microalbuminuria in non-diabetic acute ischemic stroke: an Indian perspective. Ann Indian Acad Neurol. 2005;8:237-42.

Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901-6.

Hillege HL, Wilbert MT, Janssen Annet AA. Bak, Giller IH, Dierek Diedrick E. Grobber, Harry JGM Crijns, et al. Microalbuminuria in non-diabetic non hypertensive population. J Intern Med. 2001;249:519-26.

Jafar TH, Stark PC, Schmid CH, Landa M, Mascho G, de jong PE, et al. Progression of CKD. Ann Inter Med. 2003;139:244-52.